Article by Karen B. Roberts Photo illustration by David Barczak February 15, 2021
According to Hungarian biochemist Albert Szent-Gyrgyi, who won the Nobel Prize in physiology or medicine in 1937 for his study of vitamin c and cell respiration, Innovation is seeing what everybody has seen and thinking what nobody has thought.
Most of the time, innovators do not know if their ideas will pan out. A lot of the time they dont. When failure occurs, inventors step back, reconsider and regroup, then keep pursuing their ideas, incorporating lessons learned along the way in order to pivot or start anew.
As we celebrate National Innovation Day on Tuesday, Feb. 16, UDaily asked several University of Delaware researchers who are fellows of the National Academy of Inventors to share their successes, stumbling blocks and suggestions on what it takes to innovate, invent and inspire new solutions to challenges facing society and the world.
Eleftherios (Terry) Papoutsakis is the Unidel Eugene Du Pont Chair ofChemical and Biomolecular Engineering. He was selected for NAI fellow status in December 2020 for translational biotechnology contributions that have profoundly impacted sustainable manufacturing and human health. One technology that Papoutsakis said has proven particularly useful and successful is his teams development of a method to engineer microparticles that deliver gene-regulating material to hematopoietic stem and progenitor cells that live deep in our bone marrow, where they direct the formation of blood cells. The technology could be useful in treatment for inherited blood disorders, such as sickle cell anemia, or to improve personalized medicine. The discovery, he said, was completely unexpected, but it is currently generating a lot of interest from companies.
Q: Were there inventors that you looked up to as a kid or other people or events that inspired your inventiveness?
Papoutsakis: As a child, I did not know what inventors do but I was amazed by the ability of airplanes to fly, thediscovery of plastics, fertilizers and pesticides (my dad hadan orchard and could tell how important they were) and theconcept of the vaccine. Mygeneration first experienced the benefits of the polio vaccine andvaccines for otherdevastatingdiseases. That iswhy I decided tobecome achemical engineer. I did not know at the time how broad thefield was, but I had a cousin-in-law who wasforward-looking, and he explained to me the potential of thefield and its breadth.
Q: What are some of the stumbling blocks youve encountered as an inventor? How did you overcome them?
Papoutsakis: Two things come to mind. First, I wish I had taken a course inpatent law and patent writing. I amstill learning as I go along; however, I cant help but think about what might have been different if Id had training. I missed several opportunities to protect my researchwork.
Second, Iwish I understood better how tosell (commercialize) myinventions and be good at it. It takes the right personality and athick skin to swallowwithoutpain therejections (and I lack both), plus a lot of time to keeppushing.
Q: Are the best innovators also subject-matter experts? Or do great innovations just as often or more often flow from an idea from someone who does not know how to bring that idea to life, but gets connected with someone who does?
Papoutsakis: Not necessarily, intuition and imagination are more important, I think. In terms of which is better, subject-matter expertise or connections, I think the latter is as potent anavenue as the subject-matter expertwho has intuition and imagination, orthe rightpeople towork with.
Q: What are the critical innovations we need now?
Papoutsakis: We havedone wellwith theeasy thingsthat make a lot of money like social media and the Googles and the Amazons of the world. We needthese things, and the folks that developed them aregeniuses. But we still need tosolvereallybig problems inenergy, the environment, global warming, sustainablemanufacturing and transportation. Then there is the problem of affordable and adaptable health care. The pandemic is just a reminder and anadvance notice asto whathumanity might beup against as wemoveforward.
Q: Are there ways to develop/nurture an innovative mind and keep that spark alive?
Papoutsakis: Patents are a key part of invention. I think it is important to engage both undergrads and graduate students in all aspects of the patent process early on. From patent applications to writing provisional patents and, later, work with lawyers to file the utility patents or even just to read them. It is so different from reading scientific papers. Having this knowledge and background early in ones academic or industrial career would be beneficial for an individual and for future inventors working with that individual to keep the spark alive.
Q: Is there anything you would tell your younger inventor self if you could?
Papoutsakis: At the risk of repeating myself, I would tell my younger self to take a course in patent writing and entrepreneurship, to work with a master in my field and tothink outside of the box. The best ideas are not necessarily based on expensive science.
Kristi Kiick, Blue and Gold Distinguished Professor of Materials Science and Engineering, was named a fellow of the National Academy of Inventors in 2019. Her research involves developing biomaterials to advance medicine, from healing wounds faster and improving chemotherapies, to treating heart and musculoskeletal diseases.Kiicks proudest moment of invention occurred as a graduate student at the California Institute of Technology when she discovered that the natural protein-synthesis machinery of E. coli can be tuned to use novel chemical groups not normally used by nature in protein synthesis. Specific enzymes that normally control what amino acids are included in proteins can simply be produced at higher levels in the bacterial cell. This change alone can permit an enormous range of chemically reactive proteins to be produced. Other scientists have built on Kiicks original approach to create applications that now help scientists learn about processes inside of cells in order to better understand development, disease and drug treatments.
Q: Were there inventors that you looked up to as a kid or other people or events that inspired your inventiveness?
Kiick: My exposure to and interest in invention occurred while I was a research scientist at Kimberly Clark Corporation. I was inspired by many of my co-workers, who each approached innovation and invention differently.Some people saw research articles and applied those findings to technical advances we were trying to make in our laboratories, and others found inspiration from the fundamental principles of the world around them.It was inspiring and a little bit intimidating for me to watch how these colleagues generated and implemented ideas.It definitely changed how I looked at science and its application in solving technical challenges.
Q: What are some of the stumbling blocks youve encountered as an inventor? How did you overcome them?
Kiick: Honestly, the biggest stumbling block for me was trusting my scientific intuition as a young scientist.It took me a long time to understand that my ideas could be novel and that what might appear as an experimental failure could actually be a new discovery.The thoughtful and supportive mentoring by my graduate adviser was pivotal in my making this transition.
Q: Are the best innovators also subject-matter experts? Or do great innovations just as often or more often flow from an idea from someone who does not know how to bring that idea to life, but gets connected with someone who does?
Kiick: The best innovations dont necessarily come from subject matter experts. Having a fresh look at a question or an idea can spark innovation. The implementation of many technical innovations is often best accomplished by a diverse team, where deep technical knowledge can be applied in a new way because someone has thought to look at the idea differently.
Q: What are the critical innovations we need now?
Kiick: I think there are still critical innovations to be made in how we apply massive amounts of data to create new technologies and social systems that allow us to be good stewards of our planet, our communities and ourselves.
Q: Are there ways to develop/nurture an innovative mind and keep that spark alive?
Kiick: As Walt Whitman said, Be curious, not judgmental.
Q: Is there anything you would tell your younger inventor self if you could?
Kiick: I just laughed out loud.I would say surround yourself with supportive people who are trying to make a positive difference. Say yes, and and not no, but. Travel more.Enjoy the journey.
Yushan Yan, Henry B. du Pont Chair in Chemical and Biomolecular Engineering, was named a fellow of the National Academy of Inventors in 2018. He is a co-inventor on more than 20 patents. Among his teams most recent inventions is a new class of ionically conducting polymers that have the potential to drastically reduce the cost of green hydrogen and fuel cells and to help deeply decarbonize all sectors of our economy. In 2019, Yan launched a startup called W7energy, now known as Versogen, alongside UD students and alumni to commercialize this new class of polymers and membranes. Hes proud to report that the company has grown rapidly over the last two years.
Q: Were there inventors that you looked up to as a kid or other people or events that inspired your inventiveness?
Yan: When I was a kid, I did not understand the concept of invention, per se, but I did like tinkering with my hands. For example, I enjoyed making my own primitive telescope or modifying my kerosene lamp to make it burn cleaner. Years later I would learn that what I did to the lamp was to turn the diffusion flame (where the fuel and oxidizer are separate prior to the reaction) into a premixed flame (where the fuel and oxidizer are mixed) like those found in a Bunsen burner.
Q: What are some of the stumbling blocks youve encountered as an inventor? How did you overcome them?
Yan: Coming up with an invention that is useful is not difficult, but developing a good sense of what kind of invention can be commercialized and have a measurable societal impact took some time.
Q: What are the critical innovations we need now?
Yan: As a society we still need many critical innovations in all kinds of fields. For myself, being able to reduce the cost of hydrogen and fuel cells to help deeply decarbonize our economy is a very high priority.
Q: Are there ways to develop/nurture an innovative mind and keep that spark alive?
Yan: I think it is important to instill curiosity into our children and to convince them that everyone has the potential to change what is possible.
See original here:
Inspiring innovation | UDaily - UDaily
- Personalized medicine: The pros, cons and concerns - New Atlas - November 16th, 2024
- Precision Medicine, AI, and the Future of Personalized Health Care - November 16th, 2024
- Why precision medicine results in more effective health care, treatment plans - The Business Journals - November 16th, 2024
- Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer - Inside Precision Medicine - November 16th, 2024
- More Precise Classifications of NonClear Cell RCC Are Required to Improve Personalized Treatment - OncLive - September 13th, 2024
- Bahrain aims to provide residents with personalized healthcare - Healthcare IT News - September 13th, 2024
- Precision Medicine Market Is Expected To Reach Revenue Of - GlobeNewswire - September 13th, 2024
- New Graduates Leverage Genomics Education in Clinical and Research Settings - University of Colorado Anschutz Medical Campus - June 20th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022
- AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce AI-Enabled, Patient-Centric Oncology Solutions... - June 8th, 2022
- Time to Rethink Metformin as First-Line Therapy? Perspective from ADA 2022 - Endocrinology Network - June 8th, 2022
- PreludeDx Presents New DCISionRT Data on the Effectiveness of Endocrine Therapy in DCIS Patients at the ASCO 2022 Annual Meeting - 69News WFMZ-TV - June 8th, 2022
- BITS Pilani Hyderabad to conduct 'Precision Medicine 2022' event tomorrow - United News of India - June 8th, 2022
- Global Laboratory Information Systems (LIS) Market to Reach US$2.4 Billion by the Year 2026 - Yahoo Finance - June 8th, 2022
- Medical Nutrition Market Promising Growth Opportunities and Forecast 2027 - Digital Journal - June 8th, 2022
- 57% of Organizations in India are at the Startup Stage of Genomics High-Performance Computing Infrastructure - APN News - June 8th, 2022
- Cellworks Singula TRI Provides Personalized OS and PFS Predictions for 18 NCCN Guideline GBM Therapies - StreetInsider.com - June 8th, 2022
- Inspiration for the laboratory of tomorrow - Chemie.de - June 8th, 2022
- Global Nanomaterials in Personalized Medicine Market (Impact Of COVID-19) Growth, Overview With Detailed Analysis 2022-2028 Queen Anne and Mangolia... - May 8th, 2022
- The global biomarkers market is expected to grow at a CAGR of 11.44%. - Yahoo Finance - May 8th, 2022
- Bioinformatics Market Size, Share, And Trends Analysis Report, By Application (Drug Development, Protein Function Analysis, Gene Therapy, Molecular... - May 8th, 2022
- Link between EBV and MS may give clues to the cause of long COVID - The Arizona Republic - May 8th, 2022
- Improving Cell Cultures with Thermoresponsive Coatings - Genetic Engineering & Biotechnology News - May 8th, 2022
- Reevaluating, Reimagining, And Reinventing Healthcare: Innovation In A Post-Pandemic World - Forbes - May 8th, 2022
- Study of Cancer Genetics to Help with Targeted Treatment - VOA Learning English - May 8th, 2022
- Increased demand for Molecular diagnostics after the COVID-19 outbreak - The Financial Express - May 8th, 2022
- CIOs' 5-year plans for precision medicine and emerging technologies - Healthcare IT News - January 30th, 2022
- SeqOne Genomics Closes 20M Series a to Accelerate the Deployment of Its Genomic Medicine Platform - Business Wire - January 30th, 2022
- Study: In IBS patients, cognitive behavioral therapy modulates the brain-gut microbiome and helps relieve symptoms - UB News Center - January 30th, 2022
- (New Report) Digital Genome Market In 2022 : The Increasing use in Diagnostics, Agriculture & Animal Research, Personalized Medicine, Drug... - January 30th, 2022
- Silencing a faulty gene may uncover clues to rare forms of ALS - National Institutes of Health - January 30th, 2022
- Plants, Bioprinting and Orbital Plumbing Fill Crew's Thursday Schedule - NASA - January 30th, 2022
- ClarityX DNA: The Key to Tackling Seasonal Affective Disorder - PR Web - January 30th, 2022